当前位置: 首页 >> 检索结果
81. Steal Phenomenon of Thoracic False Lumen: Imaging Insights From Postdissection Cases.
Persistent thoracic false lumen flow and subsequent aortic expansion are common complications following thoracic endovascular aortic repair for type B aortic dissection, as well as aortic arch replacement with the elephant trunk technique for type A aortic dissection. Although thoracic false lumen-perfused branches are known to contribute to thoracic false lumen backflow, robust imaging evidence is still lacking. This review illustrates how these branches perpetuate thoracic false lumen flow through detailed imaging analysis, emphasizing the critical need for advancing rapid, accurate, and minimally invasive imaging techniques and novel therapeutic devices to address this persistent clinical challenge.
82. Prolonged Extreme Asymptomatic Hypertroponinemia as a Milestone in Diagnosis of Familial Arrhythmogenic Right Ventricular Cardiomyopathy.
作者: Sergej Prijic.;Ivana Cerovic.;Vladislav Vukomanovic.;Sasa Popovic.;Maja Popovic.;Sanja Ninic.;Stasa Krasic.;Marija Zdravkovic.
来源: Circ Heart Fail. 2025年e012713页 83. Resuscitation Practices at Emergency Medical Service Agencies Working in Black and Hispanic Versus White Catchment Areas in the United States.
作者: Paul S Chan.;Saket Girotra.;Khadijah Breathett.;Kimberly C Dukes.;Jessica Sperling.;Christina M Pacheco.;Kevin F Kennedy.;Comilla Sasson.;Bryan McNally.;Heather Schacht Reisinger.;Marina Del Rios.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷6期e011799页
Although survival for out-of-hospital cardiac arrest (OHCA) is lower at emergency medical service (EMS) agencies serving Black/Hispanic communities, it is unknown whether this is due to practice differences.
84. Response by Skalidis et al to Letter Regarding Article, "Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study)".
作者: Leos Pleva.;Pavel Kukla.;Tomas Kovarnik.;Jana Zapletalova.
来源: Circ Cardiovasc Interv. 2025年e015470页 88. Validation of ICD-10 Codes to Distinguish Between Claudication and Chronic Limb-Threatening Ischemia in Patients Undergoing Peripheral Vascular Intervention Using Medicare-Matched Registry Data.
作者: Sanuja Bose.;David P Stonko.;Sharon C Kiang.;Daniel Roh.;Jialin Mao.;Andrew Cabrera.;Chen Dun.;Philip P Goodney.;James H Black.;Leigh Ann O'Banion.;Jesse A Columbo.;Roger T Tomihama.;Caitlin W Hicks.
来源: Circ Cardiovasc Qual Outcomes. 2025年e011467页
The accuracy of contemporary administrative claims codes to discriminate between different phenotypes of peripheral artery disease is not well defined. We aimed to validate a predefined set of International Classification of Diseases, Tenth Revision, codes used to distinguish between claudication and chronic limb-threatening ischemia (CLTI) and to optimize their diagnostic accuracy using a supervised machine-learning approach.
94. Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
作者: Yogesh N V Reddy.;Robert P Frantz.;Paul M Hassoun.;Anna Hemnes.;Evelyn Horn.;Jane A Leopold.;Franz Rischard.;Erika B Rosenzweig.;Nicholas S Hill.;Serpil C Erzurum.;Gerald J Beck.;J Emanuel Finet.;Christine L Jellis.;Stephen C Mathai.;Reena Mehra.;W H Wilson Tang.;Barry A Borlaug.; .
来源: Circ Heart Fail. 2025年e012912页
Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors for heart failure with preserved ejection fraction (HFpEF), but the optimal approach to identify the disease overlap remains unclear.
95. Procedural and Clinical Outcomes According to Ultrasound-Guided Access in TAVI: A Propensity-Matched Comparative Subanalysis From the PULSE Registry.
作者: David Grundmann.;Tanja Rudolph.;Matti Adam.;Caroline Kellner.;Sabine Bleiziffer.;Daniel Braun.;Alexander R Tamm.;Max Meertens.;Matthias Renker.;Jonas Gmeiner.;Alexander Sedaghat.;David Leistner.;Christian W Hamm.;Hendrik Wienemann.;Norvydas Zapustas.;Benjamin Juri.;Mostafa Salem.;Roman Benetti-Lehmann.;Henryk Dreger.;Alina Gossling.;Awesta Nahif.;Stefan Blankenberg.;Hermann Reichenspurner.;Niklas Schofer.;Andreas Schaefer.;Jasmin Popara.;Misumasa Sudo.;Martin Geyer.;Marc Vorpahl.;Derk Frank.;Max Potratz.;Won Kim.;Moritz Seiffert.
来源: Circ Cardiovasc Interv. 2025年e014771页
Access-related vascular and bleeding complications during transcatheter aortic valve implantation (TAVI) are associated with significant morbidity and mortality. Ultrasound-guided (USG) puncture may reduce the incidence of these adverse events, particularly in large-bore arterial access. However, large-scale data on this approach are limited, and it has not yet been fully implemented into standard clinical practice. We compared access-related vascular and bleeding complications in USG versus fluoroscopy-guided access from a large multicenter TAVI registry.
96. Long-Term Risk Assessment in Athletes With Complex Ventricular Arrhythmias.
作者: Paolo Compagnucci.;Michela Casella.;Maria Lucia Narducci.;Edoardo Conte.;Michela Cammarano.;Gemma Pelargonio.;Daniele Andreini.;Vincenzo Palmieri.;Giulia Stronati.;Gerardo V Lo Russo.;Matteo Brusamolino.;Gianluca Pontone.;Federico Guerra.;Andrea Natale.;Claudio Tondo.;Filippo Crea.;Paolo Zeppilli.;Antonio Dello Russo.
来源: Circ Arrhythm Electrophysiol. 2025年18卷6期e013480页
Ventricular arrhythmias (VAs) are a major concern in athletes. We sought to determine the prognostic role of noninvasive and invasive assessments in athletes with complex VAs.
97. Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program.
作者: Naman S Shetty.;Akhil Pampana.;Mokshad Gaonkar.;Nirav Patel.;Nehal Vekariya.;J Gustav Smith.;Rajat Kalra.;C Anwar A Chahal.;Christopher Semsarian.;Peng Li.;Garima Arora.;Pankaj Arora.
来源: Circ Genom Precis Med. 2025年18卷3期e005113页
This study aimed to evaluate the prevalence of pathogenic/likely pathogenic cardiomyopathy variant carriers in a multiancestry US population and examine the risk of adverse clinical outcomes.
|